Cyclin-dependent kinase inhibitor drugs as potential novel anti-inflammatory and pro-resolution agents.
about
The genetic and epigenetic landscapes of the epithelium in asthmaSustained proliferation in cancer: Mechanisms and novel therapeutic targetsInduction of eosinophil apoptosis by the cyclin-dependent kinase inhibitor AT7519 promotes the resolution of eosinophil-dominant allergic inflammationIdentification of the Rage-dependent gene regulatory network in a mouse model of skin inflammation.Harnessing Neutrophil Survival Mechanisms during Chronic Infection by Pseudomonas aeruginosa: Novel Therapeutic Targets to Dampen Inflammation in Cystic FibrosisCyclin-dependent kinase 9 may as a novel target in downregulating the atherosclerosis inflammation (Review).Cell cycle-linked MeCP2 phosphorylation modulates adult neurogenesis involving the Notch signalling pathway.R-roscovitine reduces lung inflammation induced by lipoteichoic acid and Streptococcus pneumoniae.Modulating Innate and Adaptive Immunity by (R)-Roscovitine: Potential Therapeutic Opportunity in Cystic Fibrosis.Airway Epithelial Expression Quantitative Trait Loci Reveal Genes Underlying Asthma and Other Airway Diseases.Francisella tularensis Modulates a Distinct Subset of Regulatory Factors and Sustains Mitochondrial Integrity to Impair Human Neutrophil Apoptosis.Roscovitine ameliorates endotoxin-induced uveitis through neutrophil apoptosis.Mechanisms regulating neutrophil survival and cell death.Eosinophils in the lung - modulating apoptosis and efferocytosis in airway inflammation.Switching off key signaling survival molecules to switch on the resolution of inflammation.Nucleoside diphosphate kinases (NDPKs) in animal development.Multifaceted effects of Francisella tularensis on human neutrophil function and lifespan.Targeting Neutrophilic Inflammation Using Polymersome-Mediated Cellular Delivery.Novel R-roscovitine NO-donor hybrid compounds as potential pro-resolution of inflammation agents.Roscovitine blocks leukocyte extravasation by inhibition of cyclin-dependent kinases 5 and 9.Mediators and receptors in the resolution of inflammation: drug targeting opportunities.CDK7 inhibition suppresses rheumatoid arthritis inflammation via blockage of NF-κB activation and IL-1β/IL-6 secretion.Marine-derived protein kinase inhibitors for neuroinflammatory diseases.A novel computational approach for drug repurposing using systems biology.Selective inhibition of CDK7 ameliorates experimental arthritis in mice.Unconventional apoptosis of polymorphonuclear neutrophils (PMN): staurosporine delays exposure of phosphatidylserine and prevents phagocytosis by MΦ-2 macrophages of PMN.
P2860
Q28067559-99AE156E-6C44-433D-981E-BB630B4CA75AQ28396388-65C953F3-9645-410F-A1D7-80F888C8DFACQ28477314-6C2D3E0A-0F5D-426E-AF28-C1F655CAB9D6Q33710953-024F0F94-9839-494F-9531-4CFB1D537262Q33857503-14C0EC48-76EB-4DB9-9445-4FEFAF185742Q34265421-EB247EBE-EB55-414B-AD51-62E406E9B4DBQ34890354-2C5D3C0B-5E70-42C0-829B-F1595F111D6EQ36330067-A472992D-3136-462D-A7B4-545F278C6BF7Q36709312-7A78EF20-A2F0-426C-AD50-8A57029ABC38Q36765913-165E103D-C161-4948-AF35-C6E77E991BE0Q36844736-4B82FD0D-2B03-47CC-986B-64032D2634D6Q37082991-F6DFCB8F-0BF5-4077-B2E0-4786B43361ECQ38078229-3962370E-46E2-4279-9922-D5ADF637B56BQ38234940-924DC3D5-5606-43A9-804B-623F42E0C6C6Q38241177-B123CC0C-B1BA-4E8C-9F28-329A70CAA921Q38299359-A11C3676-5B9A-475A-9441-E798A5360BDEQ38936545-1471D700-FC75-4FFF-96D7-311635D3DD9AQ40294321-CD879C12-634F-45D4-8E3A-FD3CABDD2053Q41885497-11AB495B-63F4-453A-85CF-EBBE0C53D2D9Q42099233-63CAFDDB-A06D-4AAA-A878-C2CB68159A47Q42681904-FE9DCC5B-4AA6-40FA-A228-4726D276BF66Q48105240-9C6E9042-A90A-4341-A557-C3A0B57C5670Q52565796-B0A4C4F0-329D-4166-ACF7-8EA8A7115DB9Q52657953-6E9AF16A-728F-47A4-89AC-E6C1E68CDA74Q54327713-37E6FFFB-A218-48A2-8AC8-DD653D57E5B6Q54339984-5E132294-1F65-4D5D-881B-E88EDB3AB980
P2860
Cyclin-dependent kinase inhibitor drugs as potential novel anti-inflammatory and pro-resolution agents.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cyclin-dependent kinase inhibi ...... ory and pro-resolution agents.
@en
Cyclin-dependent kinase inhibi ...... ory and pro-resolution agents.
@nl
type
label
Cyclin-dependent kinase inhibi ...... ory and pro-resolution agents.
@en
Cyclin-dependent kinase inhibi ...... ory and pro-resolution agents.
@nl
prefLabel
Cyclin-dependent kinase inhibi ...... ory and pro-resolution agents.
@en
Cyclin-dependent kinase inhibi ...... ory and pro-resolution agents.
@nl
P2093
P2860
P1476
Cyclin-dependent kinase inhibi ...... ory and pro-resolution agents.
@en
P2093
P2860
P304
P356
10.1111/J.1476-5381.2009.00402.X
P407
P577
2009-09-23T00:00:00Z